Jim Simons Gossamer Bio, Inc. Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,712,503 shares of GOSS stock, worth $2.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,712,503
Previous 1,744,805
1.85%
Holding current value
$2.24 Million
Previous $1.73 Million
10.77%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding GOSS
# of Institutions
116Shares Held
153MCall Options Held
793KPut Options Held
528K-
Octagon Capital Advisors LP New York, NY18.4MShares$24 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$23.7 Million1.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$13.1 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$11.5 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$10.6 Million4.56% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $123M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...